BOLT: Bolt Biotherapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Bolt Biotherapeutics Inc (BOLT).
$20.48M Market Cap.
BOLT Market Cap. (MRY)
BOLT Shares Outstanding (MRY)
BOLT Assets (MRY)
Total Assets
$99.63M
Total Liabilities
$42.43M
Total Investments
$63.98M
BOLT Income (MRY)
Revenue
$7.69M
Net Income
-$63.12M
Operating Expense
$80.74M
BOLT Cash Flow (MRY)
CF Operations
-$61.29M
CF Investing
$57.58M
CF Financing
$108.00K
BOLT Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $99,632,000 (-37.65%) | $159,784,000 (-29.86%) | $227,807,000 (-25.97%) | $307,718,000 (561.16%) |
Assets Current | $50,814,000 (-51.93%) | $105,708,000 (-38.81%) | $172,746,000 (-8.68%) | $189,160,000 (645.87%) |
Assets Non-Current | $48,818,000 (-9.72%) | $54,076,000 (-1.79%) | $55,061,000 (-53.56%) | $118,558,000 (459.74%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $57,198,000 (-49.27%) | $112,741,000 (-34.26%) | $171,506,000 (-31.43%) | $250,119,000 (338.33%) |
Property Plant & Equipment Net | $24,895,000 (3.40%) | $24,077,000 (-15.59%) | $28,525,000 (-6.79%) | $30,603,000 (87.17%) |
Cash & Equivalents | $7,989,000 (-26.10%) | $10,810,000 (0.01%) | $10,809,000 (-62.66%) | $28,948,000 (307.32%) |
Accumulated Other Comprehensive Income | $97,000 (162.16%) | $37,000 (104.03%) | -$919,000 (-186.29%) | -$321,000 (0%) |
Deferred Revenue | $6,635,000 (-41.32%) | $11,308,000 (-24.18%) | $14,914,000 (-12.66%) | $17,076,000 (1036.88%) |
Total Investments | $63,979,000 (-46.49%) | $119,557,000 (-34.88%) | $183,587,000 (-24.82%) | $244,184,000 (1311.79%) |
Investments Current | $40,118,000 (-56.10%) | $91,379,000 (-42.76%) | $159,644,000 (0.51%) | $158,836,000 (818.34%) |
Investments Non-Current | $23,861,000 (-15.32%) | $28,178,000 (17.69%) | $23,943,000 (-71.95%) | $85,348,000 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $1,507,000 (-49.55%) | $2,987,000 (-16.89%) | $3,594,000 (0.56%) | $3,574,000 (123.65%) |
Accumulated Retained Earnings (Deficit) | -$427,403,000 (-17.33%) | -$364,285,000 (-23.45%) | -$295,088,000 (-42.56%) | -$206,990,000 (-90.95%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $25,209,000 (24.68%) | $20,219,000 (-10.58%) | $22,611,000 (-7.16%) | $24,355,000 (123.91%) |
Debt Current | $2,251,000 (-19.09%) | $2,782,000 (16.35%) | $2,391,000 (-4.40%) | $2,501,000 (66.62%) |
Debt Non-Current | $22,958,000 (31.66%) | $17,437,000 (-13.76%) | $20,220,000 (-7.48%) | $21,854,000 (133.08%) |
Total Liabilities | $42,434,000 (-9.80%) | $47,043,000 (-16.44%) | $56,301,000 (-2.25%) | $57,599,000 (24.69%) |
Liabilities Current | $15,856,000 (-22.49%) | $20,456,000 (-11.51%) | $23,118,000 (8.39%) | $21,328,000 (89.35%) |
Liabilities Non-Current | $26,578,000 (-0.03%) | $26,587,000 (-19.88%) | $33,183,000 (-8.51%) | $36,271,000 (3.84%) |
BOLT Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $7,690,000 (-2.36%) | $7,876,000 (37.48%) | $5,729,000 (354.68%) | $1,260,000 (445.45%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $18,457,000 (-18.08%) | $22,530,000 (-1.73%) | $22,927,000 (24.65%) | $18,393,000 (103.10%) |
Research & Development Expense | $57,469,000 (-6.62%) | $61,542,000 (-15.84%) | $73,123,000 (-3.35%) | $75,655,000 (87.46%) |
Operating Expenses | $80,738,000 (-3.97%) | $84,072,000 (-12.47%) | $96,050,000 (2.13%) | $94,048,000 (90.33%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$63,118,000 (8.79%) | -$69,197,000 (21.45%) | -$88,098,000 (10.64%) | -$98,591,000 (-62.35%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$63,118,000 (8.79%) | -$69,197,000 (21.45%) | -$88,098,000 (10.64%) | -$98,591,000 (-62.35%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$63,118,000 (8.79%) | -$69,197,000 (21.45%) | -$88,098,000 (10.64%) | -$98,591,000 (-62.35%) |
Weighted Average Shares | $1,909,197 (0.98%) | $1,890,599 (1.21%) | $1,867,921 (12.54%) | $1,659,836 (1479.05%) |
Weighted Average Shares Diluted | $1,909,197 (0.98%) | $1,890,599 (1.21%) | $1,867,921 (12.54%) | $1,659,836 (1479.05%) |
Earning Before Interest & Taxes (EBIT) | -$63,118,000 (8.79%) | -$69,197,000 (21.45%) | -$88,098,000 (10.64%) | -$98,591,000 (-62.35%) |
Gross Profit | $7,690,000 (-2.36%) | $7,876,000 (37.48%) | $5,729,000 (354.68%) | $1,260,000 (445.45%) |
Operating Income | -$73,048,000 (4.13%) | -$76,196,000 (15.64%) | -$90,321,000 (2.66%) | -$92,788,000 (-88.66%) |
BOLT Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $57,576,000 (-18.95%) | $71,038,000 (22.77%) | $57,862,000 (124.92%) | -$232,201,000 (-1027.63%) |
Net Cash Flow from Financing | $108,000 (-57.31%) | $253,000 (-49.70%) | $503,000 (-99.84%) | $311,108,000 (685.69%) |
Net Cash Flow from Operations | -$61,289,000 (11.85%) | -$69,525,000 (9.12%) | -$76,504,000 (-34.06%) | -$57,066,000 (-20.63%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$3,605,000 (-304.13%) | $1,766,000 (109.74%) | -$18,139,000 (-183.05%) | $21,841,000 (177.17%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $57,469,000 (-19.33%) | $71,244,000 (19.11%) | $59,815,000 (126.02%) | -$229,863,000 (-1226.39%) |
Capital Expenditure | $107,000 (151.94%) | -$206,000 (89.45%) | -$1,953,000 (16.47%) | -$2,338,000 (28.33%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $108,000 (-57.31%) | $253,000 (-49.70%) | $503,000 (-99.81%) | $259,206,000 (88065.31%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $7,407,000 (-19.69%) | $9,223,000 (-3.69%) | $9,576,000 (12.66%) | $8,500,000 (498.59%) |
Depreciation Amortization & Accretion | $4,078,000 (-15.15%) | $4,806,000 (-1.74%) | $4,891,000 (33.20%) | $3,672,000 (46.65%) |
BOLT Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | -820.80% (6.58%) | -878.60% (42.87%) | -1537.80% (80.35%) | -7824.70% (70.24%) |
EBITDA Margin | -767.80% (6.09%) | -817.60% (43.71%) | -1452.40% (80.72%) | -7533.30% (70.11%) |
Return on Average Equity (ROAE) | -79.10% (-54.49%) | -51.20% (-15.58%) | -44.30% (-26.21%) | -35.10% (-143.60%) |
Return on Average Assets (ROAA) | -53.00% (-40.21%) | -37.80% (-8.93%) | -34.70% (-15.67%) | -30.00% (76.54%) |
Return on Sales (ROS) | -820.80% (6.58%) | -878.60% (42.87%) | -1537.80% (80.35%) | -7824.70% (70.24%) |
Return on Invested Capital (ROIC) | -55.20% (-37.66%) | -40.10% (-5.80%) | -37.90% (-6.76%) | -35.50% (84.33%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.32 (47.06%) | -0.61 (-11.07%) | -0.55 (66.61%) | -1.65 |
Price to Sales Ratio (P/S) | 2.66 (-50.59%) | 5.38 (-36.57%) | 8.48 (-93.43%) | 129.1 |
Price to Book Ratio (P/B) | 0.36 (-5.04%) | 0.38 (32.28%) | 0.28 (-60.96%) | 0.73 |
Debt to Equity Ratio (D/E) | 0.74 (77.94%) | 0.42 (27.13%) | 0.33 (42.61%) | 0.23 (152.27%) |
Earnings Per Share (EPS) | -33 (9.84%) | -36.6 (22.46%) | -47.2 (20.54%) | -59.4 (89.72%) |
Sales Per Share (SPS) | 4.03 (-3.31%) | 4.17 (35.83%) | 3.07 (304.08%) | 0.76 (-65.47%) |
Free Cash Flow Per Share (FCFPS) | -32.05 (13.11%) | -36.88 (12.19%) | -42 (-17.36%) | -35.79 (92.56%) |
Book Value Per Share (BVPS) | 29.96 (-49.76%) | 59.63 (-35.05%) | 91.82 (-39.07%) | 150.69 (115.09%) |
Tangible Assets Book Value Per Share (TABVPS) | 52.19 (-38.25%) | 84.52 (-30.70%) | 121.96 (-34.22%) | 185.39 (-58.13%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | -1 (0.00%) | -1 (50.00%) | -2 |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.48 (40.74%) | -0.81 (-13.04%) | -0.72 (62.49%) | -1.92 |
Asset Turnover | 0.07 (51.16%) | 0.04 (86.96%) | 0.02 (475.00%) | 0 (-20.00%) |
Current Ratio | 3.21 (-37.98%) | 5.17 (-30.84%) | 7.47 (-15.75%) | 8.87 (293.83%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$61,182,000 (12.26%) | -$69,731,000 (11.12%) | -$78,457,000 (-32.07%) | -$59,404,000 (-17.47%) |
Enterprise Value (EV) | $28,498,883 (-45.67%) | $52,453,774 (-12.60%) | $60,018,161 (-67.10%) | $182,410,785 |
Earnings Before Tax (EBT) | -$63,118,000 (8.79%) | -$69,197,000 (21.45%) | -$88,098,000 (10.64%) | -$98,591,000 (-62.35%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$59,040,000 (8.31%) | -$64,391,000 (22.61%) | -$83,207,000 (12.34%) | -$94,919,000 (-63.02%) |
Invested Capital | $100,996,000 (-32.10%) | $148,737,000 (-31.30%) | $216,491,000 (-23.17%) | $281,797,000 (621.67%) |
Working Capital | $34,958,000 (-58.99%) | $85,252,000 (-43.02%) | $149,628,000 (-10.85%) | $167,832,000 (1090.55%) |
Tangible Asset Value | $99,632,000 (-37.65%) | $159,784,000 (-29.86%) | $227,807,000 (-25.97%) | $307,718,000 (561.16%) |
Market Capitalization | $20,479,883 (-51.84%) | $42,521,774 (-13.15%) | $48,959,161 (-73.20%) | $182,694,785 |
Average Equity | $79,812,000 (-40.97%) | $135,204,500 (-32.08%) | $199,078,500 (-29.16%) | $281,044,000 (472.75%) |
Average Assets | $119,008,500 (-34.97%) | $183,004,000 (-27.98%) | $254,085,500 (-22.59%) | $328,244,750 (591.12%) |
Invested Capital Average | $114,293,750 (-33.78%) | $172,596,500 (-25.80%) | $232,620,250 (-16.25%) | $277,767,750 (936.18%) |
Shares | 1,913,650 (0.81%) | 1,898,294 (0.81%) | 1,883,045 (1.01%) | 1,864,232 (11.23%) |
